Please note that some translations using Google Translate may not be accurately represented and downloaded documents cannot be translated. Dana-Farber and the Jimmy Fund assume no liability for inaccuracies that may result from using this third-party tool, which is for website translation and not clinical interactions.
Osama Rahma, MD is a medical oncologist in the Center for Immuno-Oncology and the Center for Gastrointestinal Oncology at Dana-Farber Cancer Institute. Dr. Rahma’s main expertise is in cancer immunotherapy drug development, which involves identifying new targets to treat cancer and energizing the immune system against cancer. Dr. Rahma leads many national and international clinical studies using immunotherapy in a variety of malignancies. In addition, he specializes in gastrointestinal cancers and his research is focused on moving immunotherapy to colorectal and pancreatic cancers, where these therapies have not traditionally worked. Dr. Rahma also leads the Immune Toxicity Work Group at Dana-Farber and Brigham and Women Hospital, a unique program that is devoted to mitigating side effects that are caused by immunotherapy and his team is currently working on developing novel drugs that can prevent those side effects.
Philanthropic support enables Dr. Rahma and his team to conduct innovative studies that do not qualify for grant funding. Your support goes directly to Dr. Rahma. We welcome your support! You may make a secure online gift on this page, or if you prefer to send a check, please direct it to:
Dana-Farber Cancer Institute
Division of Philanthropy & The Jimmy Fund
ATTN: Hillary D. Repucci
10 Brookline Place West, 6th Floor
Brookline, MA 02445